TOPLINE The use of semaglutide was not associated with an increased risk for depression compared with placebo or other antidiabetic/antiobesity agents, but the evidence was limited and of very low certainty. METHODOLOGY Researchers conducted a systematic review and meta-analysis to assess whether semaglutide was associated with increased risk for depression in people treated for overweight…
Read More

